Pharmacokinetics of Sugammadex in Reversal of Vecuronium-induced Neuromuscular Blockade in Patients During Laparoscopic Surgery

• Status: Recruiting
• Trial end date: 2022-11-30
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to illustrate pharmacokinetics of sugammadex in reversal of vecuronium-induced neuromuscular blockade in patients during laparoscopic surgery

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Guangzhou General Hospital of Guangzhou Military Command

Criteria

Inclusion Criteria:

1. ASA: Ⅰ~Ⅲ

2. BMI≥25kg/m²

3. Patients receiving bariatric surgery.

Exclusion Criteria:

1. Pregnant or lactating women

2. Neuromuscular diseases

3. Malignant hyperthermia or allergic history during general anesthesia

4. Drugs that react with rocuronium and vecuronium were taken